225 related articles for article (PubMed ID: 11972381)
1. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
Smith HO; Qualls CR; Romero AA; Webb JC; Dorin MH; Padilla LA; Key CR
Gynecol Oncol; 2002 May; 85(2):229-41. PubMed ID: 11972381
[TBL] [Abstract][Full Text] [Related]
2. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.
Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K
Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396
[TBL] [Abstract][Full Text] [Related]
3. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
5. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
[TBL] [Abstract][Full Text] [Related]
6. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
Bisseling KC; Bekkers RL; Rome RM; Quinn MA
Gynecol Oncol; 2007 Dec; 107(3):424-30. PubMed ID: 17707895
[TBL] [Abstract][Full Text] [Related]
7. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
11. Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma? A case of recurrent FIGO stage IA1 cervical adenocarcinoma.
Utsugi K; Shimizu Y; Akiyama F; Hasumi K
Gynecol Oncol; 2001 Jul; 82(1):205-7. PubMed ID: 11426988
[TBL] [Abstract][Full Text] [Related]
12. Microinvasive adenocarcinoma of the cervix.
Spoozak L; Lewin SN; Burke WM; Deutsch I; Sun X; Herzog TJ; Wright JD
Am J Obstet Gynecol; 2012 Jan; 206(1):80.e1-6. PubMed ID: 21939955
[TBL] [Abstract][Full Text] [Related]
13. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
Reynolds EA; Tierney K; Keeney GL; Felix JC; Weaver AL; Roman LD; Cliby WA
Obstet Gynecol; 2010 Nov; 116(5):1150-7. PubMed ID: 20966701
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
15. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
[TBL] [Abstract][Full Text] [Related]
16. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
17. Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature.
Baalbergen A; Smedts F; Helmerhorst TJ
Int J Gynecol Cancer; 2011 Dec; 21(9):1640-5. PubMed ID: 21897274
[TBL] [Abstract][Full Text] [Related]
18. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
19. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994.
Cornelison TL; Trimble EL; Kosary CL
Gynecol Oncol; 1999 Sep; 74(3):350-5. PubMed ID: 10479492
[TBL] [Abstract][Full Text] [Related]
20. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
